+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

ALK Positive Non-Small Cell Lung Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

ALK Positive Non-Small Cell Lung Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

C-MET Non-Small Cell Lung Cancer (c-MET+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Malignant Pleural Mesothelioma- Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Pleural Mesothelioma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2025 - Product Thumbnail Image

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
High-Grade Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

High-Grade Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 200 Pages
  • Global
From
Castleman Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Castleman Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2025 - Product Thumbnail Image

Basal Cell Nevus Syndrome (BCNS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Angioimmunoblastic T-cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Angioimmunoblastic T-cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
FTase (Farnesyltransferase) Inhibitor- Pipeline Insight, 2025 - Product Thumbnail Image

FTase (Farnesyltransferase) Inhibitor- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Refractory Metastatic Melanoma - Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Metastatic Melanoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Natural Killer T Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Natural Killer T Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Hedgehog Pathway Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Hedgehog Pathway Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Refractory Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Relapsed Or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Or Refractory Myelodysplastic Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Lymphatic Malformations- - Pipeline Insight, 2025 - Product Thumbnail Image

Lymphatic Malformations- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Chemotherapy Induced Nausea And Vomiting - Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Nausea And Vomiting - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Advanced Urothelial Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Urothelial Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more